In vitro evaluation of Bi-213-rituximab versus external gamma irradiation for the treatment of B-CLL patients: relative biological efficacy with respect to apoptosis induction and chromosomal damage
- Author
- Katia Vandenbulcke (UGent) , Filip De Vos, Fritz Offner (UGent) , Jan Philippé (UGent) , C APOSTOLIDIS, R MOLINET, TK NIKULA, Klaus Bacher (UGent) , V DE GELDER, Anne Vral (UGent) , Christophe Lahorte, Hubert Thierens (UGent) , Rudi Dierckx (UGent) and Guido Slegers (UGent)
- Organization
-
- Department of Radiation oncology and experimental cancer research (ceased 1-10-2018)
- Department of Pharmaceutical analysis
- Department of Basic Medical Sciences (ceased 1-10-2018)
- Department of Internal medicine (ceased 1-10-2018)
- Department of Clinical chemistry, microbiology and immunology (ceased 1-10-2018)
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-215179
- MLA
- Vandenbulcke, Katia, et al. “In Vitro Evaluation of Bi-213-Rituximab versus External Gamma Irradiation for the Treatment of B-CLL Patients: Relative Biological Efficacy with Respect to Apoptosis Induction and Chromosomal Damage.” EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, vol. 30, no. 10, SPRINGER-VERLAG, 2003, pp. 1357–64.
- APA
- Vandenbulcke, K., De Vos, F., Offner, F., Philippé, J., APOSTOLIDIS, C., MOLINET, R., … Slegers, G. (2003). In vitro evaluation of Bi-213-rituximab versus external gamma irradiation for the treatment of B-CLL patients: relative biological efficacy with respect to apoptosis induction and chromosomal damage. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 30(10), 1357–1364.
- Chicago author-date
- Vandenbulcke, Katia, Filip De Vos, Fritz Offner, Jan Philippé, C APOSTOLIDIS, R MOLINET, TK NIKULA, et al. 2003. “In Vitro Evaluation of Bi-213-Rituximab versus External Gamma Irradiation for the Treatment of B-CLL Patients: Relative Biological Efficacy with Respect to Apoptosis Induction and Chromosomal Damage.” EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 30 (10): 1357–64.
- Chicago author-date (all authors)
- Vandenbulcke, Katia, Filip De Vos, Fritz Offner, Jan Philippé, C APOSTOLIDIS, R MOLINET, TK NIKULA, Klaus Bacher, V DE GELDER, Anne Vral, Christophe Lahorte, Hubert Thierens, Rudi Dierckx, and Guido Slegers. 2003. “In Vitro Evaluation of Bi-213-Rituximab versus External Gamma Irradiation for the Treatment of B-CLL Patients: Relative Biological Efficacy with Respect to Apoptosis Induction and Chromosomal Damage.” EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 30 (10): 1357–1364.
- Vancouver
- 1.Vandenbulcke K, De Vos F, Offner F, Philippé J, APOSTOLIDIS C, MOLINET R, et al. In vitro evaluation of Bi-213-rituximab versus external gamma irradiation for the treatment of B-CLL patients: relative biological efficacy with respect to apoptosis induction and chromosomal damage. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2003;30(10):1357–64.
- IEEE
- [1]K. Vandenbulcke et al., “In vitro evaluation of Bi-213-rituximab versus external gamma irradiation for the treatment of B-CLL patients: relative biological efficacy with respect to apoptosis induction and chromosomal damage,” EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, vol. 30, no. 10, pp. 1357–1364, 2003.
@article{215179, author = {{Vandenbulcke, Katia and De Vos, Filip and Offner, Fritz and Philippé, Jan and APOSTOLIDIS, C and MOLINET, R and NIKULA, TK and Bacher, Klaus and DE GELDER, V and Vral, Anne and Lahorte, Christophe and Thierens, Hubert and Dierckx, Rudi and Slegers, Guido}}, issn = {{1619-7070}}, journal = {{EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING}}, language = {{eng}}, number = {{10}}, pages = {{1357--1364}}, publisher = {{SPRINGER-VERLAG}}, title = {{In vitro evaluation of Bi-213-rituximab versus external gamma irradiation for the treatment of B-CLL patients: relative biological efficacy with respect to apoptosis induction and chromosomal damage}}, volume = {{30}}, year = {{2003}}, }